Table 2. Endplate studies.
Controls | Patient | |
---|---|---|
[125I]α-bgt binding sites/EP | 12.82±0.79 E6 (13) | 11.51 E6 |
Resting membrane potential, mV* | -72.5±0.78 (75) | -75.5±1.4 (13 fibers) |
EPP amplitude, mV† | ND | 42.6±5.05 (12) |
Quantal release at 1 Hz‡ | 31±1 (190) | 36±4.3 (12) |
MEPP amplitude, mV§ | 1.00±0.025 (165) | 1.17±0.08 (9) |
Single-channel opening bursts¶ | ||
τ2, ms | 0.12±0.012 (32) | 0.067±0.0078 (3) |
Area | 0.16±0.014 | 0.16±0.025 |
τ2, ms | 3.04±0.175 (34) | 2.91±0.32 (3) |
Area | 0.85±0.015 | 0.84±0.024 |
Values indicate mean±SEM. Measurements were made at 30°C for MEPPs and EPPs and at 22°C for single-channel recordings. Numbers in parentheses indicate number of subjects for [125I]α-bgt binding sites/EP and number of fibers or EPs for other measurements
Measured with 10-15 MΩ glass microelectrodes
Corrected for a resting membrane potential of -80 mV and nonlinear summation
Corrected for a resting membrane potential of -80 mV, nonlinear summation, and non-Poisson release
Corrected for resting membrane potential of -80 mV and for a fiber diameter of 50 μm
ACh, 1 μM; pipette potential, 80 mV; bandwidth, 5.8 kHz